Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharm Stat. 2013 Sep-Oct;12(5):309-14. doi: 10.1002/pst.1585. Epub 2013 Jul 26.

Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designs.

Author information

1
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Abstract

Consider the problem of estimating a dose with a certain response rate. Many multistage dose-finding designs for this problem were originally developed for oncology studies where the mean dose-response is strictly increasing in dose. In non-oncology phase II dose-finding studies, the dose-response curve often plateaus in the range of interest, and there are several doses with the mean response equal to the target. In this case, it is usually of interest to find the lowest of these doses because higher doses might have higher adverse event rates. It is often desirable to compare the response rate at the estimated target dose with a placebo and/or active control. We investigate which of the several known dose-finding methods developed for oncology phase I trials is the most suitable when the dose-response curve plateaus. Some of the designs tend to spread the allocation among the doses on the plateau. Others, such as the continual reassessment method and the t-statistic design, concentrate allocation at one of the doses with the t-statistic design selecting the lowest dose on the plateau more frequently.

KEYWORDS:

continual reassessment method; group up-and-down designs; phase II trials; proof of concept; t-statistic design

PMID:
23893900
PMCID:
PMC3770738
DOI:
10.1002/pst.1585
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center